Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: Evaluation of efficacy and safety

Transplantation Proceedings

Volumn 45, Issue 4, 2013, Pages 1481-1486

  Ju, M K ^a   Huh, K H ^b   Park, K T ^c   Kim, S J ^d   Cho, B H ^e   Kim, C D ^f   So, B J ^g   Kang, C M ^h   Lee, S ⁱ   Joo, D J ^b   Kim, Y S ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Chonbuk National University   (South Korea)

^f Kyungpook National University School of Medicine   (South Korea)

^g Wonkwang University   (South Korea)

^h Hanyang University   (South Korea)

ⁱ Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; URIC ACID;

ACUTE GRAFT REJECTION; ADULT; ASTHENIA; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INTENTION TO TREAT ANALYSIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; OPEN STUDY; OUTCOME ASSESSMENT; PERICARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RIBONUCLEOSIDES; TACROLIMUS; YOUNG ADULT;

EID: 84878552568     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.12.028     Document Type: Conference Paper

References (15)

1. T. Inou, R. Kusaba, I. Takahashi Clinical trial of Bredinin in renal transplantation Transplant Proc 13 1981 315
2. T. Akiyama, H. Okazaki, K. Takahashi Mizoribine in combination therapy with tacrolimus for living donor renal transplantation Transplant Proc 37 2005 843
3. Takahara S, Takahashi K, Akiyama T, et al. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation. Clin Exp Nephrol. online 21 February 2013. DOI: 10.1007/s10157-013-0780-1.
4. L.C. Racusen, R.B. Colvin, K. Solez Antibody-mediated rejection criteria - an addition to the Banff'97 classification of renal allograft rejection Am J Transplant 3 2003 708
5. J. Svedlund, I. Sjodin, G. Dotevall GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Dig Dis Sci 33 1988 129
6. E. Eypasch, J.I. Williams, S. Wood-Dauphinee Gastrointestinal Quality of Life Index: development, validation and application of a new instrument Br J Surg 82 1995 216
7. Medical Dictionary for Regulatory Activities http://www.meddramsso.com
8. K. Park, Y.S. Kim, K.I. Kwon A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults Clin Ther 29 2007 154
9. S.J. Kim, K.H. Huh, D.J. Han A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation Transplant Proc 41 2009 1671
10. R. Margreiter European Tacrolimus vs. Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomized multicentre study Lancet 359 2002 74
11. H. Ekberg, H. Tedesco-Silva, A. Demirbas Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2007 2562
12. T. Akiyama, H. Okazaki, K. Takahashi Mizoribine in combination therapy with tacrolimus for living donor renal transplantation Transplant Proc 37 2005 843
13. A. Sugitani, H. Kitada, M. Ota Revival of effective and safe high-dose mizoribine for the kidney transplantation Clin Transplant 20 2006 590
14. K. Nishimura, K. Uchida, K. Yuzawa Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan Transplant Proc 44 2012 147
15. N. Nakamura, H. Mikami, H. Matsuoka Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation Transplant Proc 44 2012 150